430 related articles for article (PubMed ID: 15878496)
1. Benefit from anti-inflammatory treatment during clinical remission of atopic asthma.
van den Toorn LM; Prins JB; de Jongste JC; Leman K; Mulder PG; Hoogsteden HC; Overbeek SE
Respir Med; 2005 Jun; 99(6):779-87. PubMed ID: 15878496
[TBL] [Abstract][Full Text] [Related]
2. Addition of fexofenadine to inhaled corticosteroid therapy to reduce inflammatory biomarkers in atopic asthma.
Fardon TC; Lee DK; Hodge MR; Lipworth BJ
Ann Allergy Asthma Immunol; 2005 Sep; 95(3):259-65. PubMed ID: 16200817
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and tolerability of salmeterol/fluticasone propionate versus montelukast in childhood asthma: A prospective, randomized, double-blind, double-dummy, parallel-group study.
Maspero J; Guerra F; Cuevas F; Gutierrez JP; Soto-Ramos M; Anderton S; Mechali D; Chan R; Pedersen S
Clin Ther; 2008 Aug; 30(8):1492-504. PubMed ID: 18803991
[TBL] [Abstract][Full Text] [Related]
4. Does measuring BHR add to guideline derived clinical measures in determining treatment for patients with persistent asthma?
Koenig SM; Murray JJ; Wolfe J; Andersen L; Yancey S; Prillaman B; Stauffer J; Dorinsky P
Respir Med; 2008 May; 102(5):665-73. PubMed ID: 18328683
[TBL] [Abstract][Full Text] [Related]
5. EXCEL: A randomised trial comparing salmeterol/fluticasone propionate and formoterol/budesonide combinations in adults with persistent asthma.
Dahl R; Chuchalin A; Gor D; Yoxall S; Sharma R
Respir Med; 2006 Jul; 100(7):1152-62. PubMed ID: 16675212
[TBL] [Abstract][Full Text] [Related]
6. Initiation of maintenance therapy with salmeterol/fluticasone propionate combination therapy in moderate asthma: a comparison with fluticasone propionate.
Rojas RA; Paluga I; Goldfrad CH; Duggan MT; Barnes N
J Asthma; 2007; 44(6):437-41. PubMed ID: 17654129
[TBL] [Abstract][Full Text] [Related]
7. Comparison between the effects of generic and original salmeterol/fluticasone combination (SFC) treatment on airway inflammation in stable asthmatic patients.
Maneechotesuwan K; Assawabhumi J; Rattanasaengloet K; Suthamsmai T; Pipopsuthipaiboon S; Udompunturak S
J Med Assoc Thai; 2014 Mar; 97 Suppl 3():S91-100. PubMed ID: 24772585
[TBL] [Abstract][Full Text] [Related]
8. Effect of fluticasone on markers of inflammation and quality of life in steroid-naive patients with mild asthma.
Ehrs PO; Sundblad BM; Larsson K
Clin Respir J; 2010 Jan; 4(1):51-8. PubMed ID: 20298418
[TBL] [Abstract][Full Text] [Related]
9. Adding salmeterol to an inhaled corticosteroid: long term effects on bronchial inflammation in asthma.
Koopmans JG; Lutter R; Jansen HM; van der Zee JS
Thorax; 2006 Apr; 61(4):306-12. PubMed ID: 16449264
[TBL] [Abstract][Full Text] [Related]
10. Tolerability of a salmeterol xinafoate/fluticasone propionate hydrofluoroalkane metered-dose inhaler in adolescent and adult patients with persistent asthma: a 52-week, open-label, stratified, parallel-group, multicenter study.
Cowie RL; Boulet LP; Keith PK; Scott-Wilson CA; House KW; Dorinsky PM
Clin Ther; 2007 Jul; 29(7):1390-402. PubMed ID: 17825690
[TBL] [Abstract][Full Text] [Related]
11. Effect of short-term treatment with low-dose inhaled fluticasone propionate on airway inflammation and remodeling in mild asthma: a placebo-controlled study.
Olivieri D; Chetta A; Del Donno M; Bertorelli G; Casalini A; Pesci A; Testi R; Foresi A
Am J Respir Crit Care Med; 1997 Jun; 155(6):1864-71. PubMed ID: 9196087
[TBL] [Abstract][Full Text] [Related]
12. Effects of salmeterol and fluticasone propionate combination versus fluticasone propionate on airway function and eosinophilic inflammation in mild asthma.
Hoshino M; Handa H; Miyazawa T
Allergol Int; 2009 Sep; 58(3):357-63. PubMed ID: 19454840
[TBL] [Abstract][Full Text] [Related]
13. Role of add-on zileuton on total exhaled, large airway, and small airway/alveolar nitric oxide in moderate-severe persistent adult asthmatics on fluticasone 250 microg/Salmeterol 50 microg.
Gelb AF; Taylor CF; Simmons M; Shinar C
Pulm Pharmacol Ther; 2009 Dec; 22(6):516-21. PubMed ID: 19467341
[TBL] [Abstract][Full Text] [Related]
14. Control of mild to moderate asthma over 1-year with the combination of salmeterol and fluticasone propionate.
Lundbäck B; Rönmark E; Lindberg A; Jonsson AC; Larsson LG; Pétavy F; James M
Respir Med; 2006 Jan; 100(1):2-10. PubMed ID: 16243498
[TBL] [Abstract][Full Text] [Related]
15. A proof of concept study to evaluate stepping down the dose of fluticasone in combination with salmeterol and tiotropium in severe persistent asthma.
Fardon T; Haggart K; Lee DK; Lipworth BJ
Respir Med; 2007 Jun; 101(6):1218-28. PubMed ID: 17178217
[TBL] [Abstract][Full Text] [Related]
16. Airway inflammation, basement membrane thickening and bronchial hyperresponsiveness in asthma.
Ward C; Pais M; Bish R; Reid D; Feltis B; Johns D; Walters EH
Thorax; 2002 Apr; 57(4):309-16. PubMed ID: 11923548
[TBL] [Abstract][Full Text] [Related]
17. Adding salmeterol to an inhaled corticosteroid reduces allergen-induced serum IL-5 and peripheral blood eosinophils.
Koopmans JG; Lutter R; Jansen HM; van der Zee JS
J Allergy Clin Immunol; 2005 Nov; 116(5):1007-13. PubMed ID: 16275368
[TBL] [Abstract][Full Text] [Related]
18. Effect of montelukast compared with inhaled fluticasone on airway inflammation.
Overbeek SE; O'Sullivan S; Leman K; Mulder PG; Hoogsteden HC; Prins JB
Clin Exp Allergy; 2004 Sep; 34(9):1388-94. PubMed ID: 15347371
[TBL] [Abstract][Full Text] [Related]
19. Vascular component of airway remodeling in asthma is reduced by high dose of fluticasone.
Chetta A; Zanini A; Foresi A; Del Donno M; Castagnaro A; D'Ippolito R; Baraldo S; Testi R; Saetta M; Olivieri D
Am J Respir Crit Care Med; 2003 Mar; 167(5):751-7. PubMed ID: 12468439
[TBL] [Abstract][Full Text] [Related]
20. The 24 h duration of bronchodilator action of the salmeterol/fluticasone combination inhaler.
Masoli M; Weatherall M; Ayling J; Williams M; Beasley R
Respir Med; 2005 May; 99(5):545-52. PubMed ID: 15823450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
